Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06535295
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-25
Brief Title:
Physical Activity Functional Capacity and Quality of Life in Older Patients With Chronic Comorbidities
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparison of Physical Activity Functional Capacity and Quality of Life Between Older Patients With Chronic Comorbidities and Healthy Peers
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The prevalence of obesity hypertension HT and type 2 diabetes T2D is increasing The adoption of an increasingly sedentary lifestyle is one of the main factors contributing to the increased incidence of chronic diseases such as obesity cardiovascular diseases HT and T2D Furthermore lack of physical activity leads to a decline in functional capacity in these individuals which facilitates the progression of HTN T2D and obesity The presence of multiple chronic comorbidities can exacerbate the negative impact on health-related quality of life The main aim of this study was to compare the levels of physical activity functional capacity and quality of life between elderly individuals with chronic comorbidities such as HTN T2D and obesity and their healthy peers Quality of life functional capacity and physical activity level will be assessed by SF-36 questionnaire 6-minute walk test and the International Physical Activity Questionnaire-short form respectively
Detailed Description:
Globally the elderly population is increasing along with a significant rise in the prevalence of chronic conditions such as obesity hypertension HT and type 2 diabetes T2D The World Health Organization WHO reported in 2021 that over 2 billion adults were overweight with more than 800 million classified as obese At the same time HT affected 128 billion adults globally and the incidence of T2D surged from 108 million in 1980 to 537 million in 2021 Focusing on the older population recent studies show that around 50 of older adults are affected by obesity approximately 529 suffer from HT and about 275 have T2D The high prevalence of chronic diseases among older adults poses a significant health challenge and strains healthcare systems globally This challenge is driven by increased life expectancy and the rapid aging of the population which together lead to a larger elderly population and consequently a higher incidence of chronic diseases
Obesity T2D and HT can lead to complications in the cardiovascular and musculoskeletal systems which in turn are likely to negatively affect PA functional capacity and QoL For instance obesity can increase the load on joints due to excessive weight thereby restricting mobility while T2D may adversely affect walking capacity through peripheral neuropathy and vascular complications Hypertension could exacerbate symptoms during PA by increasing the cardiovascular load In managing chronic diseases such as obesity HT and T2D medications play a vital role in controlling these conditions and preventing complications Nevertheless even with this treatment patients may continue to experience declines in functional capacity PA and QoL The impact of chronic diseases such as obesity HT and T2D on PA functional capacity and QoL in older adults remains unclear in the literature Although early detection and prevention of these conditions are important the specific effects on these health aspects are not well-defined Research indicates that while these conditions can influence health their impact varies among individuals and effective management may mitigate some adverse effects Further research is needed to clarify how chronic diseases such as obesity HT and T2D affect PA functional capacity and QoL in the older population as there remains a significant gap in empirical data regarding these effects
Therefore the aim of our study is to compare PA functional capacity and QoL between patients with obesity HT T2D and healthy controls and to elucidate the differing impacts of these chronic conditions on these parameters The physical activity level will be evaluated using the short form of the International Physical Activity Questionnaire IPAQ the functional capacity will be evaluated using the 6-minute walk test and the quality of life will be evaluated using the SF-36 Quality of Life Scale At the end of the study physical activity functional capacity and quality of life will be compared between older patients with chronic comorbidities and healthy peers
Obesity T2D and HT can lead to complications in the cardiovascular and musculoskeletal systems which in turn are likely to negatively affect PA functional capacity and QoL For instance obesity can increase the load on joints due to excessive weight thereby restricting mobility while T2D may adversely affect walking capacity through peripheral neuropathy and vascular complications Hypertension could exacerbate symptoms during PA by increasing the cardiovascular load In managing chronic diseases such as obesity HT and T2D medications play a vital role in controlling these conditions and preventing complications Nevertheless even with this treatment patients may continue to experience declines in functional capacity PA and QoL The impact of chronic diseases such as obesity HT and T2D on PA functional capacity and QoL in older adults remains unclear in the literature Although early detection and prevention of these conditions are important the specific effects on these health aspects are not well-defined Research indicates that while these conditions can influence health their impact varies among individuals and effective management may mitigate some adverse effects Further research is needed to clarify how chronic diseases such as obesity HT and T2D affect PA functional capacity and QoL in the older population as there remains a significant gap in empirical data regarding these effects
Therefore the aim of our study is to compare PA functional capacity and QoL between patients with obesity HT T2D and healthy controls and to elucidate the differing impacts of these chronic conditions on these parameters The physical activity level will be evaluated using the short form of the International Physical Activity Questionnaire IPAQ the functional capacity will be evaluated using the 6-minute walk test and the quality of life will be evaluated using the SF-36 Quality of Life Scale At the end of the study physical activity functional capacity and quality of life will be compared between older patients with chronic comorbidities and healthy peers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None